Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.2920

-0.0233 (-7.39%)

At close: Apr 1, 2025, 4:00 PM

0.3026

+0.0106 (3.63%)

After-hours: Apr 1, 2025, 5:05 PM EDT

Cellectar Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	25.64	11.69	10.55	6.54	5.15	Upgrade
Research & Development	26.14	27.27	18.27	17.59	10.14	Upgrade
Operating Expenses	51.78	38.96	28.81	24.13	15.29	Upgrade
Operating Income	-51.78	-38.96	-28.81	-24.13	-15.29	Upgrade
Interest & Investment Income	1.21	0.39	0.15	0	0.01	Upgrade
Other Non Operating Income (Expenses)	6.05	-4.26	-3.19	0.01	-	Upgrade
EBT Excluding Unusual Items	-44.52	-42.83	-31.85	-24.12	-15.28	Upgrade
Other Unusual Items	-	-	-	-	0.19	Upgrade
Pretax Income	-44.52	-42.83	-31.85	-24.12	-15.09	Upgrade
Income Tax Expense	0.07	-0.06	-0.06	-	-	Upgrade
Net Income	-44.58	-42.77	-31.79	-24.12	-15.09	Upgrade
Net Income to Common	-44.58	-42.77	-31.79	-24.12	-15.09	Upgrade
Shares Outstanding (Basic)	37	12	7	6	2	Upgrade
Shares Outstanding (Diluted)	37	12	7	6	2	Upgrade
Shares Change (YoY)	203.92%	73.22%	27.09%	180.20%	158.14%	Upgrade
EPS (Basic)	-1.22	-3.50	-4.51	-4.35	-7.62	Upgrade
EPS (Diluted)	-1.40	-3.50	-4.51	-4.35	-7.62	Upgrade
Free Cash Flow	-47.69	-33.24	-25.45	-22.71	-14	Upgrade
Free Cash Flow Per Share	-1.28	-2.72	-3.61	-4.09	-7.06	Upgrade
EBITDA	-51.49	-38.77	-28.67	-23.98	-15.15	Upgrade
D&A For EBITDA	0.29	0.19	0.15	0.15	0.14	Upgrade
EBIT	-51.78	-38.96	-28.81	-24.13	-15.29	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q